{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:50:23Z","timestamp":1792871423412,"version":"4.5.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T00:00:00Z","timestamp":1452038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0004341","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T18:35:39Z","timestamp":1452105339000},"page":"e0004341","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":76,"title":["Allopurinol Resistance in Leishmania infantum from Dogs with Disease Relapse"],"prefix":"10.1371","volume":"10","author":[{"given":"Daniel","family":"Yasur-Landau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Baneth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,1,6]]},"reference":[{"key":"ref1","first-page":"1","article-title":"Control of the Leishmaniases, Report of a WHO expert committee","volume":"949","year":"2010","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1471-4922(02)02347-4","article-title":"Canine leishmaniasis: epidemiological risk and the experimental model","volume":"18","author":"J Moreno","year":"2002","journal-title":"Trends Parasitol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2013-203325","article-title":"Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative","volume":"73","author":"F Sivera","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/AAC.5.5.469","article-title":"Antileishmanial effect of allopurinol","volume":"5","author":"MA Pfaller","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0304-4017(02)00115-2","article-title":"Chemotherapy of canine leishmaniosis","volume":"106","author":"G Baneth","year":"2002","journal-title":"Vet Parasitol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12639-010-0006-3","article-title":"Drug targets in <italic>Leishmania<\/italic>","volume":"34","author":"B Chawla","year":"2010","journal-title":"J Parasit Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0306-3623(97)00268-1","article-title":"The pharmacology of leishmaniasis","volume":"30","author":"R Bala\u00f1a-Fouce","year":"1998","journal-title":"Gen Pharmacol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1756-3305-4-86","article-title":"The LeishVet Group. LeishVet guidelines for the practical management of canine leishmaniosis","volume":"4","author":"L Solano-Gallego","year":"2011","journal-title":"Parasit Vectors"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13071-015-0896-0","article-title":"Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol","volume":"8","author":"L Manna","year":"2015","journal-title":"Parasit Vectors"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.vetpar.2004.12.002","article-title":"Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate","volume":"128","author":"S Pasa","year":"2005","journal-title":"Vet Parasitol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1756-3305-4-52","article-title":"Infectivity to <italic>Phlebotomus perniciosus<\/italic> of dogs naturally parasitized with <italic>Leishmania infantum<\/italic> after different treatments","volume":"4","author":"G Mir\u00f3","year":"2011","journal-title":"Parasit Vectors"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-4017(01)00399-5","article-title":"A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis","volume":"98","author":"AF Koutinas","year":"2001","journal-title":"Vet Parasitol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pt.2008.05.003","article-title":"Canine leishmaniosis-new concepts and insights on an expanding zoonosis: part two","volume":"24","author":"G Mir\u00f3","year":"2008","journal-title":"Trends Parasitol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1748-5827.1998.tb03649.x","article-title":"Use of allopurinol for maintenance of remission in dogs with leishmaniasis","volume":"39","author":"PJ Ginel","year":"1998","journal-title":"J Small Anim Practice"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1939-1676.1999.tb02190.x","article-title":"Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with <italic>Leishmania infantum<\/italic>","volume":"13","author":"T Cavaliero","year":"1999","journal-title":"J Vet Intern Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/01652176.1997.9694729","article-title":"The effect of intravenous or subcutaneous administration of meglumine antimonite (Glucantime) in dogs with leishmaniasis\u2013A randomized clinical trial","volume":"19","author":"RJ Slappendel","year":"1997","journal-title":"Vet Q"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tvjl.2007.04.013","article-title":"Real-time PCR assay in <italic>Leishmania<\/italic>-infected dogs treated with meglumine antimoniate and allopurinol","volume":"177","author":"L Manna","year":"2007","journal-title":"Vet J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tvjl.2010.05.025","article-title":"Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol","volume":"188","author":"M Torres","year":"2011","journal-title":"Vet J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2008-9-7-r115","article-title":"Modulation of gene expression in drug resistant <italic>Leishmania<\/italic> is associated with gene amplification, gene deletion and chromosome aneuploidy","volume":"9","author":"JM Ubeda","year":"2008","journal-title":"Genome Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e1167","DOI":"10.1371\/journal.pntd.0001167","article-title":"Gene expression profiling and molecular characterization of antimony resistance in <italic>Leishmania amazonensis<\/italic>","volume":"5","author":"RL do Monte-Neto","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00436-011-2555-5","article-title":"<italic>Leishmania<\/italic> antimony resistance: what we know what we can learn from the field","volume":"109","author":"K A\u00eft-Oudhia","year":"2011","journal-title":"Parasitol Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of <italic>Leishmania donovani<\/italic>","volume":"56","author":"B Purkait","year":"2012","journal-title":"Antimicrob. Agents Chemother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1371\/journal.pntd.0001512","article-title":"Ouellette M. Multiple mutations in heterogeneous miltefosine-resistant <italic>Leishmania major<\/italic> population as determined by whole genome sequencing","volume":"6","author":"AC Coelho","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","article-title":"<italic>Leishmania<\/italic> resistance to miltefosine associated with genetic marker","volume":"18","author":"S Cojean","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00034983.1992.11812717","article-title":"Decreased sensitivity to meglumine antimoniate (Glucantime) of <italic>Leishmania infantum<\/italic> isolated from dogs after several courses of drug treatment","volume":"86","author":"M Gramiccia","year":"1992","journal-title":"Ann Trop Med Parasitol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2210-2-11","article-title":"In vitro susceptibility to pentavalent antimony in <italic>Leishmania infantum s<\/italic>trains is not modified during In vitro or in vivo passages but is modified after host treatment with meglumine antimoniate","volume":"2","author":"J Carri\u00f3","year":"2002","journal-title":"BMC Pharmacology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.vetpar.2012.01.034","article-title":"In vitro susceptibility to antimonials and amphotericin B of <italic>Leishmania infantum<\/italic> strains isolated from dogs in a region lacking drug selection pressure","volume":"187","author":"K A\u00eft-Oudhia","year":"2012","journal-title":"Vet Parasitol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tvjl.2008.08.009","article-title":"Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis","volume":"182","author":"L Manna","year":"2009","journal-title":"Vet J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4269\/ajtmh.1998.59.722","article-title":"Emergence of visceral leishmaniasis in central Israel","volume":"59","author":"G Baneth","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0167-7012(02)00099-4","article-title":"Prina E. Rapid differentiation of Old World <italic>Leishmania<\/italic> species by LightCycler polymerase chain reaction and melting curve analysis","volume":"51","author":"L Nicolas","year":"2002","journal-title":"J Microbiol. methods"},{"key":"ref31","first-page":"499","article-title":"The Leishmaniases in Biology and Medicine","author":"LF Schnur","year":"1987"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.mimet.2008.05.026","article-title":"Rapid fluorescent assay for screening drugs on <italic>Leishmania<\/italic> amastigotes","volume":"75","author":"O Shimony","year":"2008","journal-title":"J Microbiol Methods"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.41.5.972","article-title":"Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents","volume":"41","author":"D Sereno","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0035-9203(00)90093-2","article-title":"Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of <italic>Leishmania donovani<\/italic> spotted on filter paper as revealed by single-strand conformation polymorphisms and sequencing","volume":"94","author":"NO el Tai","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1051\/vetres:2007015","article-title":"Splenic immune responses during canine visceral leishmaniasis","volume":"38","author":"D Strauss-Ayali","year":"2007","journal-title":"Vet Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exppara.2013.05.015","article-title":"<italic>In vitro<\/italic> drug susceptibility of <italic>Leishmania infantum<\/italic> isolated from humans and dogs","volume":"135","author":"C Maia","year":"2013","journal-title":"Exp Parasitol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1017\/S0031182009991156","article-title":"Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis","volume":"136","author":"RJ Quinnell","year":"2009","journal-title":"Parasitology"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0004341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T07:03:47Z","timestamp":1567494227000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0004341"}},"subtitle":[],"editor":[{"given":"Eric","family":"Dumonteil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,6]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0004341","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,6]]}}}